About: ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures in New Zealand and the United States. It develops Nerve Cuff, a bioabsorbable protective wrap used to protect repaired nerves; and Nerve Graft, an off-the-shelf nerve grafts for the repair of damaged nerves under the NervAlign brand. The company also offers Empliq Dermal, an acellular dermal matrix (ADM) sourced from donated human skin and designed to replace lost or damaged dermal tissue; bionic nerve, a novel combination polymer technology; and Nerve Guide Matrix for treating more severe nerve injuries but eliminating the need for patients to undergo additional sural nerve harvesting under the NervAlign brand. The company was incorporated in 2016 and is headquartered in Northcote, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.08 (-6.74%)
RNV ASX Renerve Ltd
Renerve Ltd share price
Atividade de preço de RNV
Último preço
$ 0,080
Variação (24h)
-0,01 AUD (6,74%)
Volume
30K
Volume (média 4 sem.)
-
Abertura
$ 0,09
Variação do dia
$ 0,08 - $ 0,09
Fechamento anterior
$ 0,09
Último negócio
03 Nov, 4:23 am GMT+0
Atrasado
03 Nov, 4:23 am GMT+0
RNV price performance
Atrasado
03 Nov, 4:23 am GMT+0
RNV details
quote.marketSignals